SynthesisBMC public health2025
Chronic kidney disease among patients with hypertension in sub-Saharan Africa: a systematic review and meta-analysis.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and Causes of Acute Kidney Injury and Chronic Kidney Disease in Ghana: A Systematic Review and Meta-Analysis.Journal of epidemiology and global health · 2026Pooled it
- Quality of life, sleep quality, and psychological wellbeing of patients with chronic kidney disease in Sabaragamuwa Province, Sri Lanka: a descriptive cross-sectional study.Scientific reports · 2026Article
- Prevalence and associated factors of comorbidities among hypertensive patients in Northwest Ethiopia, 2024.BMC cardiovascular disorders · 2025Article
- Incidence and predictors of chronic kidney disease among hypertensive patients in Ethiopia: A Bayesian multivariate joint model.PloS one · 2025Article
- Knowledge of Hypertension and Self-Blood Pressure Measurement Skills in Spain.Journal of primary care & community healthObservational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic kidney disease is defined by the presence of kidney damage or decreased kidney function for at least three months, irrespective of the cause. Hypertensive kidney disease is one of the long-term complications of poorly controlled hypertension. It is the second leading cause of developing chronic kidney disease, next to diabetic mellitus.
methodsThe literature was searched using an international electronic database (PubMed, Google Scholar, Hinari, and Open Google) to get significant studies on chronic kidney disease among hypertensive patients. This study is conducted to determine the pooled prevalence and associated factors of chronic kidney disease among hypertensive patients up to May 20, 2024. Heterogeneity between studies was checked using I
resultIn this meta-analysis, 16 studies in sub-Saharan Africa were included with a total of 6648 participants who fulfilled the inclusion criteria. The estimated prevalence of CKD among hypertension patients was found to be 29.01% (95% CI: 23.03-34.99, I
conclusionHypertension is one of the major causes of chronic kidney disease. Most patients living with hypertension develop CKD over time in sub-Saharan Africa. The highest prevalence of CKD among hypertension was observed in West Africa and Middle Africa.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.